A

316P Implementation of Vela Analytics to accelerate comprehensive interpretation and reporting of next-generation sequencing-based oncology testing in clinical diagnostic laboratories

Annals of Oncology, vol. 31, pp. S1365

Authors 10

  1. Yin Yu Aachen Research

    Galapagos (Netherlands) · BGI Genomics · Verge Genomics (United States)

    Affiliation as printed

    Research, Vela Genomics Pte. Ltd., Singapore

  2. Galapagos (Netherlands) · BGI Genomics · Verge Genomics (United States)

    Affiliation as printed

    Research, Vela Genomics Pte. Ltd., Singapore

  3. Galapagos (Netherlands) · BGI Genomics · Verge Genomics (United States)

    Affiliation as printed

    Research, Vela Genomics Pte. Ltd., Singapore

  4. Galapagos (Netherlands) · BGI Genomics · Verge Genomics (United States)

    Affiliation as printed

    Research, Vela Genomics Pte. Ltd., Singapore

  5. Galapagos (Netherlands) · BGI Genomics · Verge Genomics (United States)

    Affiliation as printed

    Research, Vela Genomics Pte. Ltd., Singapore

  6. Affiliation as printed

    Research, Vela Research Singapore Pte. Ltd., Singapore

  7. Affiliation as printed

    Research, Vela Research Singapore Pte. Ltd., Singapore

  8. Affiliation as printed

    Research, Vela Research Singapore Pte. Ltd., Singapore

  9. Institut Gustave Roussy

    Affiliation as printed

    Medical Biology and Pathology, Institut Gustave Roussy, Villejuif, France

  10. C. Lee Aachen Research

    Galapagos (Netherlands) · BGI Genomics · Verge Genomics (United States)

    Affiliation as printed

    Research, Vela Genomics Pte. Ltd., Singapore

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-11).

References 0